EXOBIOPHARMA

Exobiopharma S.L. is a biotechnology company specializing in nanomedicine, which designs advanced therapies, cosmetics, and medical devices based on functional exosomes and functionalized nanoparticles, with a focus on immunomodulation and personalized regenerative medicine.

It has also developed three types of disruptive technologies that address key technical limitations in the bioproduction and autologous therapies sector, such as the lack of automation, the impossibility of standardizing products under GMP regulations, and the low clinical efficacy of non-targeted treatments. Exobiopharma proposes an industrial and scalable solution with consolidated preclinical scientific evidence and a clear focus on market transfer.

The project has a solid technical, regulatory, and commercial validation strategy, including strategic international distribution agreements and a clear roadmap for CE certification and entry into clinical trials.